Molecular determinants of risk, progression and treatment response in melanoma

Project: Research

Status	Finished
Effective start/end date	1/07/14 → 31/12/15

Evaluation of commercial kits for purification of circulating free DNA
Diefenbach, R. J., Lee, J. H., Kefford, R. F. & Rizos, H., 21 Sep 2018, In: Cancer Genetics. 228-229, p. 21-27 7 p.
Research output: Contribution to journal › Article › peer-review
76 Citations (Scopus)
A multi-step classifier addressing cohort heterogeneity improves performance of prognostic biomarkers in three cancer types
Patrick, E., Schramm, S-J., Ormerod, J. T., Scolyer, R. A., Mann, G. J., Mueller, S. & Yang, J. Y. H., 2017, In: Oncotarget. 8, 2, p. 2807-2815 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
5 Citations (Scopus)

4 Downloads (Pure)
Dynamics of chemokine, cytokine, and growth factor serum levels in BRAF-mutant melanoma patients during BRAF inhibitor treatment
Wilmott, J. S., Haydu, L. E., Menzies, A. M., Lum, T., Hyman, J., Thompson, J. F., Hersey, P., Kefford, R. F., Scolyer, R. A. & Long, G. V., 1 Mar 2014, In: Journal of Immunology. 192, 5, p. 2505-2513 9 p.
Research output: Contribution to journal › Article › peer-review
59 Citations (Scopus)

Project Details